Health Care & Life Sciences » Biotechnology | Arena Pharmaceuticals Inc.

Arena Pharmaceuticals Inc. | Ownership

Companies that own Arena Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Wellington Management Co. LLP
4,769,593
9.66%
-18,552
0.04%
06/30/2018
Fidelity Management & Research Co.
4,528,549
9.18%
-796,159
0.02%
06/30/2018
The Vanguard Group, Inc.
4,446,872
9.01%
285,597
0.01%
06/30/2018
BlackRock Fund Advisors
3,560,096
7.21%
391,449
0.01%
06/30/2018
Partner Fund Management LP
2,541,981
5.15%
1,327,428
1.71%
08/16/2018
SSgA Funds Management, Inc.
2,357,529
4.78%
349,659
0.01%
06/30/2018
Point72 Asset Management LP
1,367,400
2.77%
1,030,000
0.26%
06/30/2018
Alyeska Investment Group LP
1,211,800
2.46%
527,863
0.45%
06/30/2018
Perceptive Advisors LLC
841,978
1.71%
670,000
0.75%
06/30/2018
Marshall Wace North America LP
724,288
1.47%
379,881
0.15%
06/30/2018

About Arena Pharmaceuticals

View Profile
Address
6154 Nancy Ridge Drive
San Diego California 92121
United States
Employees -
Website http://www.arenapharm.com
Updated 07/08/2019
Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.